Oncologists Frustrated Over Limits on Low-Cost Antiemetics Oncologists Frustrated Over Limits on Low-Cost Antiemetics
Current limits on low-cost generic antiemetics, allowing for example only nine ondansetron tablets each month, are leading to needless suffering and, ultimately, extra cost.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

What About This?: Ondansetron Can Treat Migraine (Yes, Ondansetron)
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - April 1, 2022 Category: Emergency Medicine Tags: What About This? Source Type: news

ondansetron
Title: ondansetronCategory: MedicationsCreated: 3/18/2022 12:00:00 AMLast Editorial Review: 3/18/2022 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - March 18, 2022 Category: Nutrition Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva informaci ón sobre la prolongación del intervalo QT con ondansetrón (Zofran)
El 29 de julio, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) está informando a los profesionales de la salud y al público que los resultados preliminares de recientes pruebas clínicas indican que una sola dosis intravenosa de 32 mg de ondansetrón (Zofran, hidrocloruro de ond ansetrón y genéricos) puede alterar la actividad eléctrica del corazón (prolongación del intervalo QT), lo cual puede predisponer a los pacientes a producir un ritmo cardiaco anormal y potencialmente mortal conocido como Torsade de Pointes. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 9, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Oral Mosapride as Anti-emetic Following General Anesthesia Oral Mosapride as Anti-emetic Following General Anesthesia
Might the addition of prophylactic oral mosapride to a protocol including dexamethasone and ondansetron further reduce postoperative nausea and vomiting after general anesthesia?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 2, 2021 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos: Informaci ón actualizada sobre la dosis intravenosa de 32 mg de ondansetrón (Zofran) y productos previamente mezclados de ondansetrón
[12-5-12] La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) notificó a los profesionales de la salud que ya no se comercializará la dosis intravenosa de 32 mg de Zofran (hidrocloruro de ondansetrón), un medicamento para prevenir las náuseas, debido al potencial de serios ri esgos para el corazón (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that preliminary results from a recently completed clinical study suggest that a 32 mg single intravenous dose of ondansetron (Zofran, ondansetron hydrochloride, and generics) may affect the electrical activity of the heart (QT interval prolongation), which could pre-dispose patients to develop an abnormal and potentially fatal heart rhythm known as Torsades de Pointes. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 8, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How a 65p pill can end the terrifying delusions that haunt thousands with Parkinson's  
A ground-breaking NHS trial will start next month, offering 200 volunteers the chance to try a drug called ondansetron which has been shown in studies to help halt hallucinations. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2020 Category: Consumer Health News Source Type: news

Featured Review: Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis
ConclusionsFor people at higher risk, some medicines worked well to stop them from being sick after general anaesthesia. The most reliable antiemetic medicines were aprepitant, ramosetron, granisetron, dexamethasone, and ondansetron, followed by fosaprepitant and droperidol.However, the authors did not find enough reliable evidence about potential unwanted effects to rank these medicines reliably according to how well they worked.Read the full review on the Cochrane LibraryVisit the Cochrane Anaesthesia Group websiteTuesday, October 20, 2020 (Source: Cochrane News and Events)
Source: Cochrane News and Events - October 15, 2020 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Bimodal Ondansetron Pill Eases Vomiting in Gastroenteritis Bimodal Ondansetron Pill Eases Vomiting in Gastroenteritis
A single long-acting tablet prevented vomiting for significantly longer than traditional medication in most recipients, a study found.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 11, 2019 Category: Internal Medicine Tags: Internal Medicine News Source Type: news

Ondansetron (Zofran) vs. palonosetron (Aloxi)
Title: Ondansetron (Zofran) vs. palonosetron (Aloxi)Category: MedicationsCreated: 7/29/2019 12:00:00 AMLast Editorial Review: 7/29/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 29, 2019 Category: Drugs & Pharmacology Source Type: news

Ondansetron (Zofran) vs. promethazine (Phenergan)
Title: Ondansetron (Zofran) vs. promethazine (Phenergan)Category: MedicationsCreated: 7/29/2019 12:00:00 AMLast Editorial Review: 7/29/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 29, 2019 Category: Drugs & Pharmacology Source Type: news

Ondansetron (Zofran) vs. metoclopramide (Reglan)
Title: Ondansetron (Zofran) vs. metoclopramide (Reglan)Category: MedicationsCreated: 7/26/2019 12:00:00 AMLast Editorial Review: 7/26/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 26, 2019 Category: Drugs & Pharmacology Source Type: news

Fresenius Kabi Issues Voluntary Nationwide Recall of Midazolam Injection, USP, 2 mg/2 mL Due to Reports of Blister Packages Containing Syringes of Ondansetron Injection, USP, 4 mg/2 mL
Fresenius Kabi USA is voluntarily recalling Lot 6400048 of Midazolam Injection, USP, 2 mg/2 mL packaged in a 2 mL prefilled single-use glass syringe to the hospital/user level. The product mislabeled as Midazolam Injection, USP, 2 mg/2 mL contains syringes containing and labeled as Ondansetron Injection, USP, 4 mg/2 mL. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 25, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ondansetron (Zofran) vs. meclizine
Title: Ondansetron (Zofran) vs. meclizineCategory: MedicationsCreated: 7/25/2019 12:00:00 AMLast Editorial Review: 7/25/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 25, 2019 Category: Drugs & Pharmacology Source Type: news